Oral vs Intravenous Dexamethasone in Total Knee Arthroplasty
Recruiting now
Conditions studied: Knee Osteoarthritis, Gonarthrosis; Primary, Total Knee Arthroplasty
In brief
This prospective observational cohort study aims to evaluate the association between perioperative dexamethasone administration and early postoperative recovery following primary total knee arthroplasty. In routine clinical practice, dexamethasone may be administered orally, intravenously, or not administered, depending on the surgeon's established perioperative protocol. The primary objective is to assess early postoperative recovery in terms of pain intensity, functional mobility, and knee joint range of motion. Secondary objectives include evaluation of inflammatory response, postoperative metabolic changes, opioid requirement, and the severity of postoperative nausea and vomiting (PONV). Group allocation is non-randomized and determined solely by the standard perioperative management approach routinely applied by the surgeon selected by the patient. No additional interventions are introduced for research purposes. All outcomes are assessed prospectively during the early postoperative period.
Key facts
- Study ID
- NCT07442812
- Run by
- Haseki Training and Research Hospital
- People needed
- 270
- Starts
- 2026-03-31
- Expected to finish
- 2027-10-01
- Last updated by the study team
- 2026-05-20
Who can join
Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age between 50 and 80 years
- Diagnosis of primary knee osteoarthritis (primary gonarthrosis)
- Scheduled for elective primary total knee arthroplasty
- ASA physical status I or II
- Ability to ambulate independently (with or without assistive devices) preoperatively
- Ability to understand study procedures and complete pain and functional assessments
- Provision of written informed consent
You may not qualify if…
- Revision total knee arthroplasty
- History of knee joint infection
- Inflammatory arthritis (e.g., rheumatoid arthritis)
- Chronic systemic corticosteroid use
- Uncontrolled diabetes mellitus
- Known endocrine disorders affecting glucose metabolism
- Active infection at any site
- Known hypersensitivity to corticosteroids
- Severe hepatic, renal, or cardiac disease
- Neurological or musculoskeletal disorders affecting gait or balance
- Inability or unwillingness to comply with study procedures
Where it is running
- Sultangazi Haseki Training and Research Hospital — Istanbul, Istanbul, Turkey (Türkiye) (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.